Letter to the editor: Japan's emergency approval system under the COVID‐19 pandemic
Main Authors: | Yudai Kaneda, Akihiko Ozaki, Tetsuya Tanimoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | Health Science Reports |
Online Access: | https://doi.org/10.1002/hsr2.1770 |
Similar Items
-
Comparing cancer drug approval systems in the United States and Japan
by: Yudai Kaneda, et al.
Published: (2023-05-01) -
Japan's COVID‐19 treatment strategy: An examination of approved oral medications
by: Yuka Higuchi, et al.
Published: (2023-11-01) -
Can the issues pointed out by ChatGPT be applied to Japan? - Examining the reasons behind high COVID-19 excess deaths in Japan
by: Yudai Kaneda, et al.
Published: (2023-06-01) -
The unprecedented avian influenza crisis in Japan: Strategies for prevention and response
by: Yudai Kaneda, et al.
Published: (2023-06-01) -
Japan's COVID-19 response: underutilized beds and misused funds
by: Yoshika Saito, et al.
Published: (2023-10-01)